Filter
Compound repurposing
Filters
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
-
Cycloheximide (HB2904)
Description:Eukaryotic protein synthesis inhibitor. Apoptosis inducer.
Purity:>95%
-
G418 disulfate salt (HB3906)
Description:Antibiotic. Widely used in cell culture. Protein synthesis inhibitor.
-
-
-
Puromycin dihydrochloride (HB4041)
Description:Protein synthesis inhibitor. Cell culture selection antibiotic.
Purity:>98%
